Effect of response quality and line of treatment with rituximab on overall and disease-free survival of patients with B-cell lymphoma

URN:NBN:SI:doc-V2VPLJFI2010Horvat, MatejaJezeršek Novaković, Barbaradocuments/znanstveni_clanki/radiology_and_oncology/html/URN_NBN_SI_doc-V2VPLJFI.htmldocuments/znanstveni_clanki/radiology_and_oncology/pdf/URN_NBN_SI_doc-V2VPLJFI.pdfdocuments/znanstveni_clanki/radiology_and_oncology/txt/URN_NBN_SI_doc-V2VPLJFI.txt4447 straniarticlestr. 232-238, III10151631318-2099URN:NBN:SI:doc-V2VPLJFIengAssociation of Radiology and OncologyRadiology and oncology (Ljubljana)BYAntigens, CD20Disease-free survivalDrug effectsDrug therapyFlow cytometrylimfomLymphoma, B-cellpreživetjerak (medicina)rituksimabSurvival analysistherapyzdravljenjeEffect of response quality and line of treatment with rituximab on overall and disease-free survival of patients with B-cell lymphoma